Can a Death Doula Support Someone with Relapsed or Refractory Multiple Myeloma?
By CRYSTAL BAI •
The short answer: Yes. A death doula can support someone with relapsed or refractory multiple myeloma (RRMM) by helping navigate multiple treatment lines and the emotional arc of repeated relapses, supporting through bone pain and renal complications, and providing compassionate presence when treatment options are exhausted.
Can a Death Doula Support Someone with Relapsed or Refractory Multiple Myeloma?
Multiple myeloma is now a chronic cancer for many patients — thanks to CAR-T therapies, bispecific antibodies, proteasome inhibitors, and immunomodulatory drugs, some patients live for 10+ years. But myeloma almost always eventually becomes relapsed and refractory (RRMM), and after exhausting available therapies, it becomes life-limiting. A death doula provides support through the full arc of this journey.
The Emotional Arc of Multiple Relapses
Myeloma patients who have experienced multiple relapses develop their own relationship to disease recurrence — some become stoic and accustomed; others find each relapse as devastating as the first. A death doula helps patients and families navigate these cycles with awareness of what has changed and what remains the same about their emotional needs.
Bone Involvement and Pain
Myeloma causes lytic bone lesions, vertebral fractures, and bone pain that can be severe. Pathological fractures, hypercalcemia, and spinal cord compression are serious complications. A death doula works alongside palliative care to advocate for adequate pain management — which is essential to quality of life in myeloma.
CAR-T and Novel Therapies: Hope and Limitations
CAR-T cell therapy (idecabtagene vicleucel, ciltacabtagene autoleucel) and bispecific antibodies (teclistamab) represent significant advances for RRMM. Some patients achieve deep remissions. But for those who progress through these agents, options narrow significantly. A death doula helps families process the transition from cutting-edge treatment to comfort-focused care.
Frequently Asked Questions
Can multiple myeloma be cured?
Multiple myeloma is generally not considered curable with current therapies outside of very select cases. Treatment focuses on achieving deep remissions and extending progression-free survival. However, many patients now live for 10+ years with myeloma, and the disease has been substantially transformed by modern therapies.
When is hospice appropriate for multiple myeloma?
Hospice may be appropriate for myeloma patients who have exhausted available treatment lines, who decline further treatment, or who have significant treatment toxicity with diminishing benefit. Hematologists and palliative care teams can facilitate hospice referral when prognosis is estimated at six months or less.
How does myeloma affect the kidneys and what happens at end of life?
Renal impairment is common in multiple myeloma from light chain deposition and hypercalcemia. End-stage kidney failure may occur in refractory myeloma. Decisions about dialysis in the context of RRMM are complex and require careful values-based discussion with palliative care and the patient.
Can a death doula support a myeloma patient who has been in treatment for many years?
Yes. Death doulas provide support through the entire myeloma journey — from diagnosis through all treatment lines and ultimately to end of life. For patients who have lived with myeloma for years, a death doula provides continuity and holds the full context of their experience.
Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.